Financhill
Buy
67

FFTY Quote, Financials, Valuation and Earnings

Last price:
$38.55
Seasonality move :
-2.47%
Day range:
$37.80 - $38.73
52-week range:
$22.91 - $41.36
Dividend yield:
1.23%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
136.9K
Avg. volume:
105.6K
1-year change:
13.3%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
FFTY
Innovator IBD 50 ETF
-- -- -- -- --
DVLU
First Trust Dorsey Wright Momentum & Value ETF
-- -- -- -- --
FPX
First Trust US Equity Opportunities ETF
-- -- -- -- --
IPO
Renaissance IPO ETF
-- -- -- -- --
MDYG
State Street SPDR S&P 400 Mid Cap Growth ETF
-- -- -- -- --
ONEO
State Street SPDR Russell 1000 Momentum Focus ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
FFTY
Innovator IBD 50 ETF
$38.07 -- -- -- $0.47 1.23% --
DVLU
First Trust Dorsey Wright Momentum & Value ETF
$37.09 -- -- -- $0.09 0.71% --
FPX
First Trust US Equity Opportunities ETF
$164.60 -- -- -- $0.23 0.53% --
IPO
Renaissance IPO ETF
$44.58 -- -- -- $0.18 0.76% --
MDYG
State Street SPDR S&P 400 Mid Cap Growth ETF
$100.54 -- -- -- $0.19 0.69% --
ONEO
State Street SPDR Russell 1000 Momentum Focus ETF
$140.20 -- -- -- $0.45 1.19% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
FFTY
Innovator IBD 50 ETF
-- 1.711 -- --
DVLU
First Trust Dorsey Wright Momentum & Value ETF
-- 1.074 -- --
FPX
First Trust US Equity Opportunities ETF
-- 1.816 -- --
IPO
Renaissance IPO ETF
-- 1.721 -- --
MDYG
State Street SPDR S&P 400 Mid Cap Growth ETF
-- 1.010 -- --
ONEO
State Street SPDR Russell 1000 Momentum Focus ETF
-- 0.712 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
FFTY
Innovator IBD 50 ETF
-- -- -- -- -- --
DVLU
First Trust Dorsey Wright Momentum & Value ETF
-- -- -- -- -- --
FPX
First Trust US Equity Opportunities ETF
-- -- -- -- -- --
IPO
Renaissance IPO ETF
-- -- -- -- -- --
MDYG
State Street SPDR S&P 400 Mid Cap Growth ETF
-- -- -- -- -- --
ONEO
State Street SPDR Russell 1000 Momentum Focus ETF
-- -- -- -- -- --

Innovator IBD 50 ETF vs. Competitors

  • Which has Higher Returns FFTY or DVLU?

    First Trust Dorsey Wright Momentum & Value ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat First Trust Dorsey Wright Momentum & Value ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FFTY
    Innovator IBD 50 ETF
    -- -- --
    DVLU
    First Trust Dorsey Wright Momentum & Value ETF
    -- -- --
  • What do Analysts Say About FFTY or DVLU?

    Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Dorsey Wright Momentum & Value ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than First Trust Dorsey Wright Momentum & Value ETF, analysts believe Innovator IBD 50 ETF is more attractive than First Trust Dorsey Wright Momentum & Value ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    FFTY
    Innovator IBD 50 ETF
    0 0 0
    DVLU
    First Trust Dorsey Wright Momentum & Value ETF
    0 0 0
  • Is FFTY or DVLU More Risky?

    Innovator IBD 50 ETF has a beta of 1.421, which suggesting that the stock is 42.128% more volatile than S&P 500. In comparison First Trust Dorsey Wright Momentum & Value ETF has a beta of 1.058, suggesting its more volatile than the S&P 500 by 5.818%.

  • Which is a Better Dividend Stock FFTY or DVLU?

    Innovator IBD 50 ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.23%. First Trust Dorsey Wright Momentum & Value ETF offers a yield of 0.71% to investors and pays a quarterly dividend of $0.09 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. First Trust Dorsey Wright Momentum & Value ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FFTY or DVLU?

    Innovator IBD 50 ETF quarterly revenues are --, which are smaller than First Trust Dorsey Wright Momentum & Value ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than First Trust Dorsey Wright Momentum & Value ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while First Trust Dorsey Wright Momentum & Value ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for First Trust Dorsey Wright Momentum & Value ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FFTY
    Innovator IBD 50 ETF
    -- -- -- --
    DVLU
    First Trust Dorsey Wright Momentum & Value ETF
    -- -- -- --
  • Which has Higher Returns FFTY or FPX?

    First Trust US Equity Opportunities ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat First Trust US Equity Opportunities ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FFTY
    Innovator IBD 50 ETF
    -- -- --
    FPX
    First Trust US Equity Opportunities ETF
    -- -- --
  • What do Analysts Say About FFTY or FPX?

    Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust US Equity Opportunities ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than First Trust US Equity Opportunities ETF, analysts believe Innovator IBD 50 ETF is more attractive than First Trust US Equity Opportunities ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    FFTY
    Innovator IBD 50 ETF
    0 0 0
    FPX
    First Trust US Equity Opportunities ETF
    0 0 0
  • Is FFTY or FPX More Risky?

    Innovator IBD 50 ETF has a beta of 1.421, which suggesting that the stock is 42.128% more volatile than S&P 500. In comparison First Trust US Equity Opportunities ETF has a beta of 1.242, suggesting its more volatile than the S&P 500 by 24.227%.

  • Which is a Better Dividend Stock FFTY or FPX?

    Innovator IBD 50 ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.23%. First Trust US Equity Opportunities ETF offers a yield of 0.53% to investors and pays a quarterly dividend of $0.23 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. First Trust US Equity Opportunities ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FFTY or FPX?

    Innovator IBD 50 ETF quarterly revenues are --, which are smaller than First Trust US Equity Opportunities ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than First Trust US Equity Opportunities ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while First Trust US Equity Opportunities ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for First Trust US Equity Opportunities ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FFTY
    Innovator IBD 50 ETF
    -- -- -- --
    FPX
    First Trust US Equity Opportunities ETF
    -- -- -- --
  • Which has Higher Returns FFTY or IPO?

    Renaissance IPO ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat Renaissance IPO ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FFTY
    Innovator IBD 50 ETF
    -- -- --
    IPO
    Renaissance IPO ETF
    -- -- --
  • What do Analysts Say About FFTY or IPO?

    Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Renaissance IPO ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than Renaissance IPO ETF, analysts believe Innovator IBD 50 ETF is more attractive than Renaissance IPO ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    FFTY
    Innovator IBD 50 ETF
    0 0 0
    IPO
    Renaissance IPO ETF
    0 0 0
  • Is FFTY or IPO More Risky?

    Innovator IBD 50 ETF has a beta of 1.421, which suggesting that the stock is 42.128% more volatile than S&P 500. In comparison Renaissance IPO ETF has a beta of 1.257, suggesting its more volatile than the S&P 500 by 25.694%.

  • Which is a Better Dividend Stock FFTY or IPO?

    Innovator IBD 50 ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.23%. Renaissance IPO ETF offers a yield of 0.76% to investors and pays a quarterly dividend of $0.18 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. Renaissance IPO ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FFTY or IPO?

    Innovator IBD 50 ETF quarterly revenues are --, which are smaller than Renaissance IPO ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than Renaissance IPO ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while Renaissance IPO ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for Renaissance IPO ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FFTY
    Innovator IBD 50 ETF
    -- -- -- --
    IPO
    Renaissance IPO ETF
    -- -- -- --
  • Which has Higher Returns FFTY or MDYG?

    State Street SPDR S&P 400 Mid Cap Growth ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat State Street SPDR S&P 400 Mid Cap Growth ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FFTY
    Innovator IBD 50 ETF
    -- -- --
    MDYG
    State Street SPDR S&P 400 Mid Cap Growth ETF
    -- -- --
  • What do Analysts Say About FFTY or MDYG?

    Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P 400 Mid Cap Growth ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than State Street SPDR S&P 400 Mid Cap Growth ETF, analysts believe Innovator IBD 50 ETF is more attractive than State Street SPDR S&P 400 Mid Cap Growth ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    FFTY
    Innovator IBD 50 ETF
    0 0 0
    MDYG
    State Street SPDR S&P 400 Mid Cap Growth ETF
    0 0 0
  • Is FFTY or MDYG More Risky?

    Innovator IBD 50 ETF has a beta of 1.421, which suggesting that the stock is 42.128% more volatile than S&P 500. In comparison State Street SPDR S&P 400 Mid Cap Growth ETF has a beta of 1.086, suggesting its more volatile than the S&P 500 by 8.61%.

  • Which is a Better Dividend Stock FFTY or MDYG?

    Innovator IBD 50 ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.23%. State Street SPDR S&P 400 Mid Cap Growth ETF offers a yield of 0.69% to investors and pays a quarterly dividend of $0.19 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. State Street SPDR S&P 400 Mid Cap Growth ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FFTY or MDYG?

    Innovator IBD 50 ETF quarterly revenues are --, which are smaller than State Street SPDR S&P 400 Mid Cap Growth ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than State Street SPDR S&P 400 Mid Cap Growth ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while State Street SPDR S&P 400 Mid Cap Growth ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for State Street SPDR S&P 400 Mid Cap Growth ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FFTY
    Innovator IBD 50 ETF
    -- -- -- --
    MDYG
    State Street SPDR S&P 400 Mid Cap Growth ETF
    -- -- -- --
  • Which has Higher Returns FFTY or ONEO?

    State Street SPDR Russell 1000 Momentum Focus ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat State Street SPDR Russell 1000 Momentum Focus ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    FFTY
    Innovator IBD 50 ETF
    -- -- --
    ONEO
    State Street SPDR Russell 1000 Momentum Focus ETF
    -- -- --
  • What do Analysts Say About FFTY or ONEO?

    Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR Russell 1000 Momentum Focus ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than State Street SPDR Russell 1000 Momentum Focus ETF, analysts believe Innovator IBD 50 ETF is more attractive than State Street SPDR Russell 1000 Momentum Focus ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    FFTY
    Innovator IBD 50 ETF
    0 0 0
    ONEO
    State Street SPDR Russell 1000 Momentum Focus ETF
    0 0 0
  • Is FFTY or ONEO More Risky?

    Innovator IBD 50 ETF has a beta of 1.421, which suggesting that the stock is 42.128% more volatile than S&P 500. In comparison State Street SPDR Russell 1000 Momentum Focus ETF has a beta of 0.999, suggesting its less volatile than the S&P 500 by 0.092999999999999%.

  • Which is a Better Dividend Stock FFTY or ONEO?

    Innovator IBD 50 ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.23%. State Street SPDR Russell 1000 Momentum Focus ETF offers a yield of 1.19% to investors and pays a quarterly dividend of $0.45 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. State Street SPDR Russell 1000 Momentum Focus ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios FFTY or ONEO?

    Innovator IBD 50 ETF quarterly revenues are --, which are smaller than State Street SPDR Russell 1000 Momentum Focus ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than State Street SPDR Russell 1000 Momentum Focus ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while State Street SPDR Russell 1000 Momentum Focus ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for State Street SPDR Russell 1000 Momentum Focus ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    FFTY
    Innovator IBD 50 ETF
    -- -- -- --
    ONEO
    State Street SPDR Russell 1000 Momentum Focus ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
73
HYMC alert for Feb 19

Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.

Buy
57
GLBE alert for Feb 19

Global-e Online Ltd. [GLBE] is up 4.19% over the past day.

Sell
37
ACLS alert for Feb 19

Axcelis Technologies, Inc. [ACLS] is down 1.71% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock